The Senate Finance Committee faces opposition from the pharmaceutical industry after releasing a bipartisan drug-pricing proposal on Tuesday that could potentially cap seniors’ out-of-pocket costs and limit price increases in Medicare.
The Senate Finance Committee faces opposition from the pharmaceutical industry after releasing a bipartisan drug-pricing proposal on Tuesday that could potentially cap seniors’ out-of-pocket costs and limit price increases in Medicare.
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to:
